CD4 and type 1 diabetes mellitus: Treatment with anti-IL-7Rα antibodies for two weeks delays T1D incidence and upregulates LAG-3, Tim-3, and PD-1 on peripheral blood CD4 and CD8 T cells from prediabetic NOD mice (114).